Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Are FDA And CMS Growing Apart? AEI’s Gottlieb Thinks So

Executive Summary

While many pharmaceutical industry observers like to talk about the new ways in which FDA and CMS are working together and sharing information, Scott Gottlieb is offering a contrarian view on relations between the two agencies

You may also be interested in...

Heads Of FDA, CMS And Other HHS Agencies May Be Named Within A Few Weeks

HHS Secretary-nominee Tom Daschle tells Senate HELP Committee there needs to be better coordination within the department.

Baucus Wants To Keep Comparative Effectiveness Separate From Cost Control

One of the first skirmishes in the 2009 health care reform debate is likely to occur over comparative effectiveness

Hypertensives May Get Class Outcome Labels; Industry Wary Of Broad Efficacy

Two major drug companies with significant hypertension profiles are welcoming the proposed inclusion of class-wide cardiovascular outcomes data in antihypertensive drug labeling - in contrast to other firms that commented on the FDA draft guidance

Related Content

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts